These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27836754)

  • 21. Compare and contrast the effects of surfactants (PluronicF-127 and CremophorEL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme.
    Haj-Ahmad RR; Elkordy AA; Chaw CS; Moore A
    Eur J Pharm Sci; 2013 Jul; 49(4):519-34. PubMed ID: 23712374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
    Liu J; Nguyen MD; Andya JD; Shire SJ
    J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined dynamic light scattering and Raman spectroscopy approach for characterizing the aggregation of therapeutic proteins.
    Lewis EN; Qi W; Kidder LH; Amin S; Kenyon SM; Blake S
    Molecules; 2014 Dec; 19(12):20888-905. PubMed ID: 25514228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linking the solution viscosity of an IgG2 monoclonal antibody to its structure as a function of pH and temperature.
    Cheng W; Joshi SB; Jain NK; He F; Kerwin BA; Volkin DB; Middaugh CR
    J Pharm Sci; 2013 Dec; 102(12):4291-304. PubMed ID: 24142544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2.
    Hu Y; Toth RT; Joshi SB; Esfandiary R; Middaugh CR; Volkin DB; Weis DD
    J Pharm Sci; 2020 Jan; 109(1):353-363. PubMed ID: 31195015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.
    Wen L; Zheng X; Wang X; Lan H; Yin Z
    Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the effects of solution additives on heat- and refolding-induced aggregation.
    Hamada H; Takahashi R; Noguchi T; Shiraki K
    Biotechnol Prog; 2008; 24(2):436-43. PubMed ID: 18386919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of viscosity in biopharmaceutical protein formulations.
    Zidar M; Rozman P; Belko-Parkel K; Ravnik M
    J Colloid Interface Sci; 2020 Nov; 580():308-317. PubMed ID: 32688122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of protein phase diagrams by microbatch experiments: exploring the influence of precipitants and pH.
    Baumgartner K; Galm L; Nötzold J; Sigloch H; Morgenstern J; Schleining K; Suhm S; Oelmeier SA; Hubbuch J
    Int J Pharm; 2015 Feb; 479(1):28-40. PubMed ID: 25541147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of polymer surface characteristics on the microrheological measurement quality of protein solutions - A tracer particle screening.
    Bauer KC; Schermeyer MT; Seidel J; Hubbuch J
    Int J Pharm; 2016 May; 505(1-2):246-54. PubMed ID: 27025292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Effects of Multiple Excipients on Controlling Viscosity of Concentrated Protein Dispersions.
    Yang D; Walker LM
    J Pharm Sci; 2023 May; 112(5):1379-1387. PubMed ID: 36539064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of proteins by agarose native gel electrophoresis in the presence of solvent additives.
    Tomioka Y; Arakawa T; Akuta T; Nakagawa M; Ishibashi M
    Int J Biol Macromol; 2022 Feb; 198():26-36. PubMed ID: 34954298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
    Sauer D; McGinity JW
    Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
    Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
    MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysozyme as diffusion tracer for measuring aqueous solution viscosity.
    Parmar AS; Muschol M
    J Colloid Interface Sci; 2009 Nov; 339(1):243-8. PubMed ID: 19664778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viscosity-Reducing Bulky-Salt Excipients Prevent Gelation of Protein, but Not Carbohydrate, Solutions.
    Kumar A; Klibanov AM
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1491-1496. PubMed ID: 28116573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of aggregate formation on the viscosity of protein solutions.
    Nicoud L; Lattuada M; Yates A; Morbidelli M
    Soft Matter; 2015 Jul; 11(27):5513-22. PubMed ID: 26061258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions.
    Bolli R; Woodtli K; Bärtschi M; Höfferer L; Lerch P
    Biologicals; 2010 Jan; 38(1):150-7. PubMed ID: 19931468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.